139 related articles for article (PubMed ID: 34732663)
1. Impact of thymosin α1 as an immunomodulatory therapy on long-term survival of non-small cell lung cancer patients after R0 resection: a propensity score-matched analysis.
Guo CL; Mei JD; Jia YL; Gan FY; Tang YD; Liu CW; Zeng Z; Yang ZY; Deng SY; Sun X; Liu LX
Chin Med J (Engl); 2021 Nov; 134(22):2700-2709. PubMed ID: 34732663
[TBL] [Abstract][Full Text] [Related]
2. Propensity-matched analysis of adjuvant chemotherapy for completely resected Stage IB non-small-cell lung cancer patients.
Li X; Zhang C; Sun Z; Yang F; Xiao R; Sui X; Jiang G; Zhong W; Wang J
Lung Cancer; 2019 Jul; 133():75-82. PubMed ID: 31200832
[TBL] [Abstract][Full Text] [Related]
3. Thymosin alpha-1 therapy improves postoperative survival after curative resection for solitary hepatitis B virus-related hepatocellular carcinoma: A propensity score matching analysis.
Linye H; Zijing X; Wei P; Chao H; Chuan L; Tianfu W
Medicine (Baltimore); 2021 May; 100(20):e25749. PubMed ID: 34011034
[TBL] [Abstract][Full Text] [Related]
4. Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non-small cell lung cancer.
Zhang P; Duan J; Bai H; Wang Z; Gao S; Tan F; Gao Y; Wang X; Wan R; Xu J; He X; Feng X; Yu R; Sun J; Zhao Z; Fei K; Li N; He J; Wang J
Thorac Cancer; 2021 Jan; 12(1):30-39. PubMed ID: 33111432
[TBL] [Abstract][Full Text] [Related]
5. Role of postoperative radiotherapy after curative resection and adjuvant chemotherapy for patients with pathological stage N2 non-small-cell lung cancer: a propensity score matching analysis.
Kim BH; Kim HJ; Wu HG; Kang CH; Kim YT; Lee SH; Kim DW
Clin Lung Cancer; 2014 Sep; 15(5):356-64. PubMed ID: 24996882
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of limited resection vs. inadequate adjuvant therapy in patients with pathologic stage II or III non-small cell lung cancer: results from the Korean Association of Lung Cancer Registry.
Lee J; Cho JS; Kim YD; Ahn HY; ;
Ann Palliat Med; 2024 Mar; 13(2):230-239. PubMed ID: 38509646
[TBL] [Abstract][Full Text] [Related]
7. Impact of age on adjuvant chemotherapy after radical resection in patients with non-small cell lung cancer.
Zhai X; Yang L; Chen S; Zheng Q; Wang Z
Cancer Med; 2016 Sep; 5(9):2286-93. PubMed ID: 27367482
[TBL] [Abstract][Full Text] [Related]
8. Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC.
Shen ZQ; Feng KP; Fang ZY; Xia T; Pan S; Ding C; Xu C; Ju S; Chen J; Li C; Zhao J
J Cardiothorac Surg; 2024 Jan; 19(1):1. PubMed ID: 38166960
[TBL] [Abstract][Full Text] [Related]
9. Thymalfasin, a promising adjuvant therapy in small hepatocellular carcinoma after liver resection.
He C; Peng W; Li C; Wen TF
Medicine (Baltimore); 2017 Apr; 96(16):e6606. PubMed ID: 28422855
[TBL] [Abstract][Full Text] [Related]
10. Optimal Adjuvant Therapy in Resected Stage IIIA-N2 Non-Small-Cell Lung Cancer Harboring EGFR Mutations.
Wen M; Wang L; Wang X; Yang S; Sun Y; Xia J; Zhang Y; Zhang Z; Huang L; Jiang T
Oncol Res Treat; 2020; 43(12):686-693. PubMed ID: 33197924
[TBL] [Abstract][Full Text] [Related]
11. Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients.
Wang J; Wu N; Lv C; Yan S; Yang Y
J Cancer Res Clin Oncol; 2019 Feb; 145(2):463-469. PubMed ID: 30474757
[TBL] [Abstract][Full Text] [Related]
12. EGFR inhibitors as adjuvant therapy for resected non-small cell lung cancer harboring EGFR mutations.
Tang W; Li X; Xie X; Sun X; Liu J; Zhang J; Wang C; Yu J; Xie P
Lung Cancer; 2019 Oct; 136():6-14. PubMed ID: 31421260
[TBL] [Abstract][Full Text] [Related]
13. Propensity score-matched analysis of adjuvant chemotherapy for stage I non-small cell lung cancer.
Tsutani Y; Miyata Y; Kushitani K; Takeshima Y; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1179-85. PubMed ID: 25112928
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant Chemotherapy Improves Survival in pN-positive Clinical Stage IIIA Non-Small Cell Lung Cancer After Neoadjuvant Therapy and Resection.
Atay SM; Amini M; Ding L; David EA; Mcfadden PM; Wightman SC; Kim AW
Ann Thorac Surg; 2021 Jul; 112(1):197-205. PubMed ID: 33121965
[TBL] [Abstract][Full Text] [Related]
15. Gefitinib Versus Adjuvant Chemotherapy in Patients With Stage II-IIIA Non-Small-Cell Lung Cancer Harboring Positive EGFR Mutations: A Single-Center Retrospective Study.
Xie H; Wang H; Xu L; Li M; Peng Y; Cai X; Feng Z; Ren W; Peng Z
Clin Lung Cancer; 2018 Nov; 19(6):484-492. PubMed ID: 30369426
[TBL] [Abstract][Full Text] [Related]
16. Intentional Segmentectomy for Clinical T1 N0 Non-small Cell Lung Cancer: Survival Differs by Segment.
Jones GD; Caso R; Choe G; Tan KS; Connolly JG; Dycoco J; Molena D; Park BJ; Huang J; Adusumilli PS; Bott MJ; Downey RJ; Travis WD; Jones DR; Rocco G
Ann Thorac Surg; 2021 Mar; 111(3):1028-1035. PubMed ID: 32739257
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of intrapulmonary lymph node dissection in pathological stage IA non-small cell lung cancer: A propensity score matching analysis.
Sun Y; Zhang Q; Wang Z; Shao F
Thorac Cancer; 2021 May; 12(10):1589-1597. PubMed ID: 33793088
[TBL] [Abstract][Full Text] [Related]
18. Risk stratification and adjuvant chemotherapy after radical resection based on the clinical risk scores of patients with stage IB-IIA non-small cell lung cancer.
Zhai W; Duan F; Li D; Yan Q; Dai S; Zhang B; Wang J
Eur J Surg Oncol; 2022 Apr; 48(4):752-760. PubMed ID: 34620508
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of pre-resection albumin/fibrinogen ratio in patients with non-small cell lung cancer: A propensity score matching analysis.
Chen S; Yan H; Du J; Li J; Shen B; Ying H; Zhang Y; Chen S
Clin Chim Acta; 2018 Jul; 482():203-208. PubMed ID: 29653085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
